Основная статистика
| CIK | 1123979 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Senomyx, Inc.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| November 13, 2018 |
15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-50791 Senomyx, Inc. (Exact name of registrant as specified in its |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
S-8 POS As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
POS AM As filed with the Securities and Exchange Commission on November 2, 2018 Registration No. |
|
| November 2, 2018 |
Seventh Amended and Restated Certificate of Incorporation of Senomyx, Inc. EX-3.1 Exhibit 3.1 SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SENOMYX, INC. FIRST. The name of the corporation is Senomyx, Inc. (the “Corporation”). SECOND. The registered office of the Corporation in the State of Delaware is to be located at 251 Little Falls Drive, Wilmington, Delaware 19808, in the County of New Castle. The registered agent of the Corporation at that address is |
|
| November 2, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File |
|
| November 2, 2018 |
Second Amended and Restated Bylaws of Senomyx, Inc. EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF SENOMYX, INC. (a Delaware corporation) Effective as of November 2, 2018 SECOND AMENDED AND RESTATED BYLAWS OF SENOMYX, INC. ARTICLE I OFFICES Section 1.1 Offices. The registered office of Senomyx, Inc. (the “Corporation”) shall be in the State of Delaware. The Corporation may have offices at such other places, both within and without the Sta |
|
| November 2, 2018 |
SNMX / Senomyx, Inc. SC 14D9/A SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 (Amendment No. 4) SENOMYX, INC. (Name of Subject Company) SENOMYX, INC. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 |
|
| November 2, 2018 |
SNMX / Senomyx, Inc. SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 4) Senomyx, Inc. (Name of Subject Company (Issuer)) Sentry Merger Sub, Inc. ( Offeror ) A wholly owned subsidiary of Firmenich Incorporated (Parent of Offeror) (Names of Filing Persons) Common S |
|
| November 2, 2018 |
EX-99.(a)(5)(C) Exhibit (a)(5)(C) PRESS RELEASE FIRMENICH SUCCESSFULLY COMPLETES TENDER OFFER TO ACQUIRE SENOMYX Geneva, Switzerland, Princeton, New Jersey and San Diego, CA, November 2, 2018 — Firmenich is pleased to announce the completion of its acquisition of Senomyx, Inc. (“Senomyx”), a global leader in taste innovation and expert in sweet, cooling and bitter solutions. Strengthening Firmenic |
|
| October 25, 2018 |
SNMX / Senomyx, Inc. AMENDMENT NO. 3 TO SCHEDULE 14D-9 Amendment No. 3 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 (Amendment No. 3) SENOMYX, INC. (Name of Subject Company) SENOMYX, INC. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class o |
|
| October 24, 2018 |
SNMX / Senomyx, Inc. SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 3) Senomyx, Inc. (Name of Subject Company (Issuer)) Sentry Merger Sub, Inc. (Offeror) A wholly owned subsidiary of Firmenich Incorporated (Parent of Offeror) (Names of Filing Persons) Common Sto |
|
| October 24, 2018 |
SNMX / Senomyx, Inc. AMENDMENT NO. 2 TO SCHEDULE 14D-9 Amendment No. 2 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 (Amendment No. 2) SENOMYX, INC. (Name of Subject Company) SENOMYX, INC. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class o |
|
| October 12, 2018 |
SNMX / Senomyx, Inc. AMENDMENT NO. 2 TO SCHEDULE TO-T Amendment No. 2 to Schedule TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) Senomyx, Inc. (Name of Subject Company (Issuer)) Sentry Merger Sub, Inc. (Offeror) A wholly owned subsidiary of Firmenich Incorporated (Parent of Offeror) (Names of Fil |
|
| October 12, 2018 |
SNMX / Senomyx, Inc. AMENDMENT NO.1 TO SCHEDULE 14D-9 Amendment No.1 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 (Amendment No. 1) SENOMYX, INC. (Name of Subject Company) SENOMYX, INC. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of |
|
| October 4, 2018 |
SNMX / Senomyx, Inc. SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) Senomyx, Inc. (Name of Subject Company (Issuer)) Sentry Merger Sub, Inc. (Offeror) A wholly owned subsidiary of Firmenich Incorporated (Parent of Offeror) (Names of Filing Persons) Common Sto |
|
| October 4, 2018 |
EX-99.(a)(5)(B) Exhibit (a)(5)(B) PRESS RELEASE FIRMENICH COMMENCES TENDER OFFER TO ACQUIRE SENOMYX Geneva, Switzerland, Princeton, New Jersey and San Diego, CA, October 4, 2018 — Firmenich Incorporated (“Firmenich”) announced today that its wholly-owned U.S. subsidiary, Sentry Merger Sub, Inc. (“Sentry Merger Sub”), commenced the previously announced tender offer to acquire all of the outstanding |
|
| October 4, 2018 |
AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(29) Exhibit (e)(29) AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Kenneth J. Simone (the “Employee”). RECITALS: A. The Employee and the Company entered into a certain Change in Contro |
|
| October 4, 2018 |
EX-99.(e)(30) Exhibit (e)(30) June 9, 2017 Antony (Tony) Rogers 4767 Nexus Center Drive San Diego, CA 92121 Dear Tony: This letter (the “Agreement”) sets forth the terms of your continuing part-time employment with Senomyx, Inc. (the “Company”) effective as of July 28, 2017. 1. Terms of Service. Effective July 28, 2017 you will resign from the position of Senior Vice President and Chief Financial |
|
| October 4, 2018 |
THIRD AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT EX-99.(e)(21) Exhibit (e)(21) THIRD AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT THIS THIRD AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and John Poyhonen (the “Employee”). RECITALS: A. The Employee and t |
|
| October 4, 2018 |
AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(27) Exhibit (e)(27) AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Guy Servant (the “Employee”). RECITALS: A. The Employee and the Company entered into a certain Change in Control Agre |
|
| October 4, 2018 |
AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(26) Exhibit (e)(26) AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Lorenzo Pena (the “Employee”). RECITALS: A. The Employee and the Company entered into a certain Change in Control Agr |
|
| October 4, 2018 |
SC 14D9 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 4, 2018 |
SECOND AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(23) Exhibit (e)(23) SECOND AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS SECOND AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Catherine C. Lee (the “Employee”). RECITALS: A. The Employee and the Company entered into a certain Cha |
|
| October 4, 2018 |
AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(28) Exhibit (e)(28) AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Andrew Patron (the “Employee”). RECITALS: A. The Employee and the Company entered into a certain Change in Control Ag |
|
| October 4, 2018 |
AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT EX-99.(e)(22) Exhibit (e)(22) AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Sharon Wicker (the “Employee”). RECITALS: A. The Employee and the Company e |
|
| October 4, 2018 |
AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(24) Exhibit (e)(24) AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Dave Humphrey (the “Employee”). RECITALS: A. The Employee and the Company entered into a certain Change in Control Ag |
|
| October 4, 2018 |
EX-99.(e)(32) Exhibit (e)(32) CONFIDENTIALITY AGREEMENT THIS CONFIDENTIALITY AGREEMENT (“Agreement”) is being entered into as of April 13, 2018, between Senomyx, Inc. (the “Company”) and Firmenich, SA (“Counterparty”). In order to facilitate the consideration and negotiation of a potential negotiated transaction between the Company and Counterparty (the “Transaction”), each of the Company and Coun |
|
| October 4, 2018 |
AMENDMENT TO CHANGE IN CONTROL AGREEMENT EX-99.(e)(25) Exhibit (e)(25) AMENDMENT TO CHANGE IN CONTROL AGREEMENT THIS AMENDMENT TO CHANGE IN CONTROL AGREEMENT (this “Amendment”) is made and entered into as of September 4, 2018 (the “Amendment Date”), by and between SENOMYX, INC., a Delaware corporation (the “Company”), and Susie Melody (formerly, Susie Firestone) (the “Employee”). RECITALS: A. The Employee and the Company entered into a c |
|
| October 4, 2018 |
EX-99.(a)(1)(E) Exhibit (a)(1)(E) Letter to Clients with respect to Offer to Purchase All Outstanding Shares of Common Stock of Senomyx, Inc. at $1.50 Per Share of Common Stock, Net in Cash Pursuant to the Offer to Purchase dated October 4, 2018 by Sentry Merger Sub, Inc. a wholly owned subsidiary of Firmenich Incorporated THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME |
|
| October 4, 2018 |
EX-99.(a)(1)(D) Exhibit (a)(1)(D) Letter to Brokers and Dealers with respect to Offer to Purchase All Outstanding Shares of Common Stock of Senomyx, Inc. at $1.50 Per Share of Common Stock, Net in Cash Pursuant to the Offer to Purchase dated October 4, 2018 by Sentry Merger Sub, Inc. a wholly owned subsidiary of Firmenich Incorporated THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, |
|
| October 4, 2018 |
EX-99.(a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal to Tender Shares of Common Stock of Senomyx, Inc. at $1.50 Per Share of Common Stock, Net in Cash Pursuant to the Offer to Purchase dated October 4, 2018 by Sentry Merger Sub, Inc. a wholly owned subsidiary of Firmenich Incorporated THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME, ON NOVEMBER 2, 2018 (ONE MINUTE AF |
|
| October 4, 2018 |
EX-99.(a)(1)(F) Exhibit (a)(1)(F) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). The Offer (as defined below) is made solely pursuant to the Offer to Purchase, dated October 4, 2018, and the related Letter of Transmittal, and any amendment or supplement to such Offer to Purchase or Letter of Transmittal. Purchaser is not aware of |
|
| October 4, 2018 |
SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 Senomyx, Inc. (Name of Subject Company (Issuer)) Sentry Merger Sub, Inc. (Offeror) A wholly owned subsidiary of Firmenich Incorporated (Parent of Offeror) (Names of Filing Persons) Common Stock, par value $0.001 |
|
| October 4, 2018 |
EX-99.(a)(1)(C) Exhibit (a)(1)(C) Notice of Guaranteed Delivery for Tender Shares of Common Stock of Senomyx, Inc. at $1.50 Per Share of Common Stock, Net in Cash Pursuant to the Offer to Purchase dated October 4, 2018 by Sentry Merger Sub, Inc. a wholly owned subsidiary of Firmenich Incorporated THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME, ON NOVEMBER 2, 2018 (ONE |
|
| October 4, 2018 |
EX-99.(a)(1)(A) Table of Contents Exhibit (a)(1)(A) Offer to Purchase All Outstanding Shares of Common Stock of Senomyx, Inc. at $1.50 Per Share of Common Stock, Net in Cash by Sentry Merger Sub, Inc. a wholly owned subsidiary of Firmenich Incorporated THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME, ON NOVEMBER 2, 2018 (ONE MINUTE AFTER 11:59 P.M., EASTERN TIME, ON NOV |
|
| September 26, 2018 |
SNMX / Senomyx, Inc. / Firmenich Inc - SC 13D Activist Investment SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Senomyx, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 81724Q107 (CUSIP Number) Douglas Lucht Vice President - Finance Firmenich Incorporated 250 Plainsboro Road Plainsboro, New Jersey 08536 (609) 452-1000 (Name, Ad |
|
| September 26, 2018 |
EX-99.3 Exhibit 3 Joint Filing Agreement We, the undersigned, hereby express our agreement that the attached Schedule 13D is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. This agreement may be terminated with respect to the ob |
|
| September 19, 2018 |
SNMX / Senomyx, Inc. / Senvest Management, LLC - SENOMYX, INC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Senomyx, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 81724Q107 (CUSIP Number) September 17, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| September 17, 2018 |
SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 Senomyx, Inc. (Name of Subject Company (Issuer)) Sentry Merger Sub, Inc. (Offeror) A wholly owned subsidiary of Firmenich Incorporated (Parent of Offeror) (Names of Filing Persons) Common Stock, par value $0.001 |
|
| September 17, 2018 |
EX-99.1 Exhibit 99.1 PRESS RELEASE FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION Geneva, Switzerland, Princeton, New Jersey and San Diego, California September 17th, 2018 – Firmenich and Senomyx, Inc. (NASDAQ: SNMX) today announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per sh |
|
| September 17, 2018 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among: SENOMYX, INC., a Delaware corporation; FIRMENICH INCORPORATED, a Delaware corporation; and SENTRY MERGER SUB, INC., a Delaware corporation Dated as of September 16, 2018 TABLE OF CONTENTS Page SECTION 1. THE OFFER 2 1.1 The Offer 2 1.2 Company Actions 4 SECTION 2. MERGER TRANSACTION 5 2.1 Merger of Purchaser into the Company |
|
| September 17, 2018 |
SC14D9C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 SENOMYX, INC. (Name of Subject Company) SENOMYX, INC. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 (CUSIP Number of Cla |
|
| September 17, 2018 |
EX-99.2 Exhibit 99.2 Execution Version TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 16, 2018, is entered into by and among Firmenich, Incorporated, a Delaware corporation (“Parent”), Sentry Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Purchaser”), and each of the persons set forth on Schedule A hereto ( |
|
| September 17, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission Fi |
|
| September 17, 2018 |
EX-99.1 Exhibit 99.1 PRESS RELEASE FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION Geneva, Switzerland, Princeton, New Jersey and San Diego, California September 17th, 2018 – Firmenich and Senomyx, Inc. (NASDAQ: SNMX) today announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per sh |
|
| September 17, 2018 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among: SENOMYX, INC., a Delaware corporation; FIRMENICH INCORPORATED, a Delaware corporation; and SENTRY MERGER SUB, INC., a Delaware corporation Dated as of September 16, 2018 TABLE OF CONTENTS Page SECTION 1. THE OFFER 2 1.1 The Offer 2 1.2 Company Actions 4 SECTION 2. MERGER TRANSACTION 5 2.1 Merger of Purchaser into the Company |
|
| September 17, 2018 |
EX-99.2 4 d624360dex992.htm EX-99.2 Exhibit 99.2 Execution Version TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 16, 2018, is entered into by and among Firmenich, Incorporated, a Delaware corporation (“Parent”), Sentry Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Purchaser”), and each of the persons set |
|
| September 17, 2018 |
EX-99.2 Exhibit 99.2 September 17, 2018 Dear Senomyx Employees, I have important and exciting news to share with you about a significant announcement we made this morning describing Firmenich’s intent to acquire Senomyx. Together, we have revolutionized the discovery of innovative flavor ingredients and natural high intensity sweeteners using our proprietary taste receptor-based assays and screeni |
|
| September 17, 2018 |
EX-99.1 Exhibit 99.1 PRESS RELEASE FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION Geneva, Switzerland, Princeton, New Jersey and San Diego, California September 17th, 2018 – Firmenich and Senomyx, Inc. (NASDAQ: SNMX) today announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per sh |
|
| September 17, 2018 |
SC14D9C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 SENOMYX, INC. (Name of Subject Company) SENOMYX, INC. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 (CUSIP Number of Cla |
|
| September 17, 2018 |
Employee—Frequently Asked Questions EX-99.3 Exhibit 99.3 EmployeeFrequently Asked Questions Whats happening? Senomyx, Inc. (Senomyx) has entered into an agreement to be acquired by Firmenich for $1.50 per share, or approximately $75 million. Who is Firmenich? Firmenich is the worlds largest privately-owned company in the fragrance and flavor business. Founded in Geneva, Switzerland, in 1895, it has created many of the worlds b |
|
| August 15, 2018 |
Exhibit 10.31 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2 AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND FIRMENICH SA AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVLOPMENT, COMMERCIALIZATION AND LIC |
|
| August 15, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-50791 Senomy |
|
| August 2, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-08438 |
|
| August 2, 2018 |
Senomyx Reports Second Quarter 2018 Financial Results Exhibit 99.1 Senomyx Reports Second Quarter 2018 Financial Results SAN DIEGO, CA – August 2, 2018 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results for the secon |
|
| August 2, 2018 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SEN |
|
| July 19, 2018 |
Senomyx Achieves Proof of Concept for Siratose Fermentation Strain EXHIBIT 99.1 Senomyx Achieves Proof of Concept for Siratose Fermentation Strain SAN DIEGO, CA – July 19, 2018 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, has achieved a fermentation strain |
|
| July 19, 2018 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-084384 |
|
| May 31, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-0843840 |
|
| April 26, 2018 |
Senomyx Reports First Quarter 2018 Financial Results Exhibit 99.1 Senomyx Reports First Quarter 2018 Financial Results SAN DIEGO, CA – April 26, 2018 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results for the first |
|
| April 26, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-08438 |
|
| April 26, 2018 |
SNMX / Senomyx, Inc. FORM 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SE |
|
| April 9, 2018 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| April 9, 2018 |
DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| March 22, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-08438 |
|
| March 22, 2018 |
Senomyx Appoints Tom Erdmann to Board of Directors Exhibit 99.1 Senomyx Appoints Tom Erdmann to Board of Directors SAN DIEGO, CA – March 22, 2018 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, has appointed Tom Erdmann to its Board of Directo |
|
| March 8, 2018 |
Senomyx Reports Fourth Quarter and Fiscal Year 2017 Financial Results Exhibit 99.1 Senomyx Reports Fourth Quarter and Fiscal Year 2017 Financial Results SAN DIEGO, CA – March 8, 2018 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial result |
|
| March 8, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-084384 |
|
| March 8, 2018 |
Exhibit 10.31 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2 AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND FIRMENICH SA AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVLOPMENT, COMMERCIALIZATION AND LIC |
|
| March 8, 2018 |
Power of Attorney. Reference is made to the signature page. 10-K 1 snmx2017123110k.htm FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm |
|
| February 16, 2018 |
Senomyx 2018 Executive Bonus Plan ex105419.htm Exhibit 99.1 Senomyx 2018 Executive Bonus Plan The Senomyx 2018 Executive Bonus Plan (the ?Bonus Plan?) has been designed to align plan participants with the goals and business strategy of Senomyx, Inc. (?Senomyx? or ?the Company?). This Bonus Plan is an important part of the Company?s commitment to recognize employees who contribute significantly to successful company performance and |
|
| February 16, 2018 |
8-K 1 snmx201802168k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2018 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50 |
|
| February 14, 2018 |
SNMX / Senomyx, Inc. / Lagoda Investment Management, L.P. Passive Investment THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* SENOMYX, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| November 30, 2017 |
Senomyx, Inc. REGAINS COMPLIANCE With nasdaq minimum bid price listing requirement ex101224.htm Exhibit 99.1 Senomyx, Inc. REGAINS COMPLIANCE With nasdaq minimum bid price listing requirement SAN DIEGO, CA - November 30, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, a |
|
| November 30, 2017 |
Financial Statements and Exhibits 8-K 1 snmx20171129b8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-5 |
|
| November 15, 2017 |
snmx201711148k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| November 14, 2017 |
Senomyx Expands Cool Program Collaboration with Firmenich ex100421.htm Exhibit 99.1 Senomyx Expands Cool Program Collaboration with Firmenich SAN DIEGO, CA ? November 14, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners, and Firmenich, the world?s largest privately-owned company in the fragrance and fla |
|
| November 14, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 snmx201711138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50 |
|
| November 2, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition snmx201710318k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| November 2, 2017 |
Senomyx Reports Third Quarter 2017 Financial Results ex98448.htm Exhibit 99.1 Senomyx Reports Third Quarter 2017 Financial Results SAN DIEGO, CA ? November 2, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results |
|
| November 2, 2017 |
SNMX / Senomyx, Inc. FORM 10-Q (Quarterly Report) 10-Q 1 snmx2017101810q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission Fi |
|
| September 1, 2017 |
Amended and Restated Bylaws as currently in effect. ex3-1.htm Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF SENOMYX, INC. (A DELAWARE CORPORATION) ARTICLE I Offices Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be in the City of Dover, County of Kent. Section 2. Other Offices. The corporation shall also have and maintain an office or principal place of business at such place as may be fixed by th |
|
| September 1, 2017 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx20170830b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| August 3, 2017 |
PROSPECTUS Common Stock Preferred Stock Debt Securities snmx201707198k.htm Filed pursuant to Rule 424(b)(3) Registration No. 333-219507 PROSPECTUS $50,000,000 Common Stock Preferred Stock Debt Securities Warrants From time to time, we may offer up to $50,000,000 of any combination of the securities described in this prospectus in one or more offerings. We may also offer securities as may be issuable upon conversion, redemption, repurchase, exchange or |
|
| August 1, 2017 |
snmx20170801corresp.htm Senomyx, Inc. 4767 Nexus Centre Drive San Diego, CA 92121 August 1, 2017 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jonathan Burr John Reynolds Pamela Howell Re: Senomyx, Inc. Registration Statement on Form S-3 Filed July 27, 2017 File No. 333-219507 Ladies and Gentlemen: Pursuant to |
|
| July 27, 2017 |
Senomyx Announces Second Quarter 2017 Financial Results ex99-1.htm Exhibit 99.1 Senomyx Announces Second Quarter 2017 Financial Results SAN DIEGO, CA ? July 27, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results f |
|
| July 27, 2017 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201707258k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fil |
|
| July 27, 2017 |
Exhibit 4.6 SENOMYX, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [], 20 SENOMYX, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENT PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between SENOMYX, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having |
|
| July 27, 2017 |
SNMX / Senomyx, Inc. FORM 10-Q (Quarterly Report) 10-Q 1 snmx2017063010q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Nu |
|
| July 27, 2017 |
Exhibit 4.5 SENOMYX, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [], 20 SENOMYX, INC. FORM OF COMMON STOCK WARRANT AGREEMENT COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between SENOMYX, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corpora |
|
| July 27, 2017 |
Exhibit 4.2 SENOMYX, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of , 20 Debt Securities Table of Contents Page article 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 article 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee’s Certificate 8 Section 2.03 Den |
|
| July 27, 2017 |
Exhibit 4.7 SENOMYX, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [], 20 SENOMYX, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENT DEBT SECURITIES WARRANT AGREEMENT (this ?Agreement?), dated as of between SENOMYX, INC., a Delaware corporation (the ?Company?), and , a [corporation] [national banking association] organized and existing under the laws of and having |
|
| July 27, 2017 |
STATEMENT REGARDING COMPUTATION OF RATIOS Exhibit 12.1 STATEMENT REGARDING COMPUTATION OF RATIOS Year Ended December 31, Six Months Ended June 30, 2012 2013 2014 2015 2016 2017 (in thousands) Earnings: Net loss $ (9,186 ) $ (11,898 ) $ (12,150 ) $ (12,648 ) $ (10,686 ) $ (6,264 ) Add: Fixed Charges 553 451 342 424 422 190 Earnings as defined $ (8,633 ) $ (11,447 ) $ (11,808 ) $ (12,224 ) $ (10,264 ) $ (6,074 ) Fixed Charges: Estimated int |
|
| July 27, 2017 |
As filed with the Securities and Exchange Commission on July 27, 2017 As filed with the Securities and Exchange Commission on July 27, 2017 Registration No. |
|
| June 16, 2017 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201706168k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fil |
|
| June 9, 2017 |
ex99-1.htm Exhibit 99.1 Senomyx, Inc. Announces Resignation of Chief Financial Officer and Promotion of New Vice President of Finance SAN DIEGO, CA - June 9, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient |
|
| June 9, 2017 |
ex10-1.htm Exhibit 10.1 June 9, 2017 Antony (Tony) Rogers 4767 Nexus Center Drive San Diego, CA 92121 Dear Tony: This letter (the ?Agreement?) sets forth the terms of your continuing part-time employment with Senomyx, Inc. (the ?Company?) effective as of July 28, 2017. 1. Terms of Service. Effective July 28, 2017 you will resign from the position of Senior Vice President and Chief Financial Office |
|
| June 9, 2017 |
snmx201706088k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File |
|
| May 22, 2017 |
Senomyx FORM 8-K/A (Current Report/Significant Event) snmx201705228ka.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 11, 2017 Senomyx, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 000-50791 33-0843840 (State or Other Jurisdiction of |
|
| May 22, 2017 |
ex99-1.htm Exhibit 99.1 Senomyx Confirms Previously Announced Results of 2017 Annual Meeting All Senomyx Director Nominees Re-Elected to Board Announces Agreement with Dissident Group, Resulting in Formal Withdrawal of Dissident Nominees and Three-Year Standstill SAN DIEGO, May 22, 2017 ? Senomyx, Inc. (?Senomyx? or the ?Company?) (NASDAQ: SNMX) today confirmed that Senomyx shareholders voted in a |
|
| May 22, 2017 |
ex10-1.htm Exhibit 10.1 STANDSTILL AGREEMENT This STANDSTILL AGREEMENT (this “Agreement”) is made and entered into as of May 19, 2017, among Senomyx, Inc., a Delaware corporation (the “Company”), on the one hand, and each of Barry A. Igdaloff, VCM Group LLC, Lee D. Keddie, Benjamin E. Large, Gus D. Halas, David W. Pointer, Mark D. Stolper, and Charles M. Gillman (collectively, “CSNS”), on the othe |
|
| May 22, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| May 17, 2017 |
snmx20170517defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 17, 2017 |
ex99-1.htm Exhibit 99.1 Senomyx Announces Results of 2017 Annual Meeting The Company Believes All Board Director Nominees were Duly Reelected Dissident Shareholders Attempted to Subvert the Election by Intentionally Breaking Quorum Senomyx to Pursue Legal Action to Affirm Election Results SAN DIEGO, May 17, 2017 ? Senomyx, Inc. (?Senomyx? or the ?Company?) (NASDAQ: SNMX) today announced the result |
|
| May 17, 2017 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201705178k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 11, 2017 Senomyx, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 000-50791 33-0843840 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 2, 2017 |
snmx20170428defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| April 27, 2017 |
Senomyx Announces First Quarter 2017 Financial Results ex99-1.htm Exhibit 99.1 Senomyx Announces First Quarter 2017 Financial Results SAN DIEGO, CA ? April 27, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results f |
|
| April 27, 2017 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201704268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fi |
|
| April 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 snmx2017033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File N |
|
| April 25, 2017 |
[title] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? De |
|
| April 21, 2017 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☒ Soliciting Material Pursuant to (S)240. |
|
| April 20, 2017 |
snmx20170420defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| April 5, 2017 |
snmx20170405defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 31, 2017 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240. |
|
| March 30, 2017 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 30, 2017 | ||
| March 29, 2017 |
snmx20170323prer14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as pe |
|
| March 29, 2017 |
snmx20170328defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 27, 2017 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 27, 2017 | ||
| March 24, 2017 |
snmx20170323prer14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as p |
|
| March 24, 2017 |
snmx20170323corresp.htm Kai H. Liekefett [email protected] Tel +1.212.237.0037 Fax +1.713.237.0100 March 24, 2017 Via EDGAR, Email and Federal Express Christina Chalk Senior Special Counsel Office of Mergers and Acquisitions United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Re: Senomyx, Inc. PREC14A, Filed March 10, 2 |
|
| March 21, 2017 |
ex10-2.htm Exhibit 10.2 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2. AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND PEPSICO, INC. AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZ |
|
| March 21, 2017 |
Senomyx FORM 10-Q/A (Quarterly Report) snmx2016093010qa.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission |
|
| March 17, 2017 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 10, 2017 |
snmx20170309prec14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as pe |
|
| March 9, 2017 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☒ Soliciting Material Pursuant to (S)240. |
|
| March 8, 2017 |
snmx201703068k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fil |
|
| March 2, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 snmx201703018k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 |
|
| March 2, 2017 |
Senomyx Announces FOURTH Quarter AND FULL YEAR 2016 Financial Results ex99-1.htm Exhibit 99.1 Senomyx Announces FOURTH Quarter AND FULL YEAR 2016 Financial Results SAN DIEGO, CA ? March 2, 2017 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural zero calorie sweeteners for the food, beverage, and ingredient supply industries, today reported financi |
|
| March 2, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 snmx2016123110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 24, 2017 |
snmx201702238k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2017 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| February 24, 2017 |
Senomyx 2017 Executive Bonus Plan ex99-1.htm Exhibit 99.1 Senomyx 2017 Executive Bonus Plan The Senomyx 2017 Executive Bonus Plan (the ?Bonus Plan?) has been designed to align plan participants with the goals and business strategy of Senomyx, Inc. (?Senomyx? or ?the Company?). This Bonus Plan is an important part of the Company?s commitment to recognize employees who contribute significantly to successful company performance and a |
|
| January 24, 2017 |
SNMX / Senomyx, Inc. / Lagoda Investment Management, L.P. - SC 13G/A Passive Investment THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SENOMYX, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| December 22, 2016 |
Up to $14,000,000 of Common Stock and 294,118 Shares of Common Stock as Commitment Shares Filed pursuant to Rule 424(b)(5) Registration No. 333-197775 PROSPECTUS SUPPLEMENT (To Prospectus dated August 11, 2014) Up to $14,000,000 of Common Stock and 294,118 Shares of Common Stock as Commitment Shares This prospectus supplement and the accompanying prospectus relate to the issuance and sale of up to $14,000,000 in shares of our common stock, and an additional 294,118 shares of common sto |
|
| December 22, 2016 |
Senomyx FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 22, 2016 |
Exhibit 10.1 PURCHASE AGREEMENT PURCHASE AGREEMENT (the ?Agreement?), dated as of December 21, 2016, by and between SENOMYX, INC., a Delaware corporation (the ?Company?), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the ?Investor?). WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wi |
|
| December 6, 2016 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201612058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| December 5, 2016 |
8-K 1 snmx201612028k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-507 |
|
| October 27, 2016 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201610268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| October 27, 2016 |
SENOMYX ANNOUNCES THIRD QUARTER 2016 FINANCIAL RESULTS Exhibit 99.1 SENOMYX ANNOUNCES THIRD QUARTER 2016 FINANCIAL RESULTS SAN DIEGO, CA ? October 27, 2016 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the third quarter ended September 30, 2016. |
|
| October 27, 2016 |
Exhibit 10.1 July 27, 2016 CONFIDENTIAL Rene Lammers, Ph.D SVP, PepsiCo Global Beverage R&D 700 Anderson Hill Road Purchase, New York 10577 Re: Extension of Collaboration Agreement Dear Dr. Lammers: This letter agreement (“Letter Agreement”) confirms the terms of our agreement to extend, on an interim basis, the term of the Collaborative R&D Period under that certain Collaborative Research, Develo |
|
| October 27, 2016 |
Exhibit 10.2 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2. AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND PEPSICO, INC. AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND L |
|
| October 27, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SENOMYX, INC. (E |
|
| September 30, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits snmx201609288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commissio |
|
| September 30, 2016 |
SENOMYX AND PEPSICO EXTEND SWEET TASTE PROGRAM COLLABORATION FOR THREE ADDITIONAL YEARS ex99-1.htm Exhibit 99.1 SENOMYX AND PEPSICO EXTEND SWEET TASTE PROGRAM COLLABORATION FOR THREE ADDITIONAL YEARS SAN DIEGO, September 30, 2016 - Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that it has amended and |
|
| July 28, 2016 |
SENOMYX ANNOUNCES SECOND QUARTER 2016 FINANCIAL RESULTS ex99-1.htm Exhibit 99.1 SENOMYX ANNOUNCES SECOND QUARTER 2016 FINANCIAL RESULTS SAN DIEGO, CA ? July 28, 2016 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the second quarter ended June 30, 2 |
|
| July 28, 2016 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx20160727b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fi |
|
| July 28, 2016 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201607278k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fil |
|
| July 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q snmx2016063010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 S |
|
| May 24, 2016 |
Submission of Matters to a Vote of Security Holders snmx201605238k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File |
|
| April 28, 2016 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201604268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fi |
|
| April 28, 2016 |
SENOMYX ANNOUNCES FIRST QUARTER 2016 FINANCIAL RESULTS ex99-1.htm Exhibit 99.1 SENOMYX ANNOUNCES FIRST QUARTER 2016 FINANCIAL RESULTS SAN DIEGO, CA ? April 28, 2016 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the first quarter ended March 31, 2 |
|
| April 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q snmx2016033110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 |
|
| April 8, 2016 |
snmx20160329def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as per |
|
| March 9, 2016 |
snmx201603098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fil |
|
| March 3, 2016 |
Senomyx Announces FOURTH Quarter AND FULL YEAR 2015 Financial Results ex99-1.htm Exhibit 99.1 Senomyx Announces FOURTH Quarter AND FULL YEAR 2015 Financial Results SAN DIEGO, CA ? March 3, 2016 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the fourth quarter an |
|
| March 3, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition snmx20160302b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fi |
|
| March 3, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K snmx2015123110k.htm nop UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-50791 Se |
|
| March 3, 2016 |
Employment letter agreement dated May 9, 2014 between Senomyx, Inc. and Catherine C. Lee. EX-10.21 2 ex10-21.htm EXHIBIT 10.21 Exhibit 10.21 May 9, 2014 Catherine C. Lee 4681 Dunham Way San Diego, CA 92130 Dear Cathy: We are pleased to extend to you an offer to join Senomyx, Inc. (the “Company”) as our Vice President, General Counsel and Corporate Secretary. The following terms apply and will constitute your employment agreement with the Company (the “Agreement”). 1. Employment. 1.1 Te |
|
| March 3, 2016 |
Exhibit 10.22 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT This First Amendment to Employment Agreement (this ?Amendment?) is made and entered into as of February 19, 2016 (the ?Amendment Date?), by and between Senomyx, Inc., a Delaware corporation (the ?Company?), and Catherine C. Lee (the ?Employee?). Recitals: A. The Employee and the Company entered into that certain Employment Agreement effective a |
|
| February 26, 2016 |
Senomyx 2016 Executive Bonus Plan ex99-1.htm Exhibit 99.1 Senomyx 2016 Executive Bonus Plan The Senomyx 2016 Executive Bonus Plan (the “Bonus Plan”) has been designed to align plan participants with the goals and business strategy of Senomyx, Inc. (“Senomyx” or “the Company”). This Bonus Plan is an important part of the Company’s commitment to recognize employees who contribute significantly to successful company performance and a |
|
| February 26, 2016 |
8-K 1 snmx201602248k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2016 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50 |
|
| February 12, 2016 |
Senomyx SENOMYX, INC. (Passive Acquisition of More Than 5% of Shares) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Senomyx, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| January 5, 2016 |
SNMX / Senomyx, Inc. / Lagoda Investment Management, L.P. - AMENDMENT NO. 1 Passive Investment SC 13G/A 1 senomyx13gam1dec312015.htm AMENDMENT NO. 1 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* SENOMYX, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this State |
|
| October 29, 2015 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201510288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| October 29, 2015 |
SENOMYX ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS ex99-1.htm Exhibit 99.1 SENOMYX ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS SAN DIEGO, CA ? October 29, 2015 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the third quarter of 2015. ?Durin |
|
| October 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SENOMYX, INC. (E |
|
| October 1, 2015 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201509308k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission F |
|
| October 1, 2015 |
ex10-1.htm Exhibit 10.1 October 1, 2015 Dear Don: This letter (the ?Agreement?) sets forth the terms of your continuing employment with Senomyx, Inc. (the ?Company?) effective as of October 1, 2015. 1. Terms of Service. Effective October 1, 2015 you will retire and resign from the position of Senior Vice President and Chief Scientific Officer. As of that date, your continuing service will be as a |
|
| September 14, 2015 |
poastebbins.htm POWER OF ATTORNEY The undersigned, as a Section 16 reporting person of Senomyx, Inc. (the ?Company?), hereby constitutes and appoints each of John Poyhonen, Antony Rogers, David Humphrey, Catherine Lee and Thomas Coll, and each of them, the undersigned's true and lawful attorney-in-fact to: I. Complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such |
|
| September 11, 2015 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201509108k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commissio |
|
| September 11, 2015 |
Dan stebbins JOINS THE BOARD OF DIRECTORS OF SENOMYX, INC. snmx201509108k.htm Exhibit 99.1 Dan stebbins JOINS THE BOARD OF DIRECTORS OF SENOMYX, INC. SAN DIEGO, CA ? September 11, 2015 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Dan Stebbins has joined the Company? |
|
| August 28, 2015 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201508278k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission F |
|
| July 30, 2015 |
SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS snmx201507288k.htm Exhibit 99.1 SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS SAN DIEGO, CA ? July 30, 2015 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the second quarter 2015. ?M |
|
| July 30, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition snmx201507288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fil |
|
| July 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SENOMYX, INC. (Exact |
|
| May 27, 2015 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201505268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File |
|
| April 30, 2015 |
Senomyx FORM 8-K (Current Report/Significant Event) snmx201504288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission Fi |
|
| April 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SENOMYX, INC. (Exact |
|
| April 30, 2015 |
SENOMYX ANNOUNCES FIRST QUARTER 2015 FINANCIAL RESULTS ex99-1.htm Exhibit 99.1 SENOMYX ANNOUNCES FIRST QUARTER 2015 FINANCIAL RESULTS SAN DIEGO, CA ? April 30, 2015 ? Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the first quarter 2015. ?Senomyx ha |
|
| April 8, 2015 |
snmx20150327def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as per |
|
| February 26, 2015 |
Senomyx 2015 Executive Bonus Plan snmx201502248k.htm Exhibit 99.1 Senomyx 2015 Executive Bonus Plan The Senomyx 2015 Executive Bonus Plan (the “Bonus Plan”) has been designed to align plan participants with the goals and business strategy of Senomyx, Inc. (“Senomyx” or “the Company”). This Bonus Plan is an important part of the Company’s commitment to recognize employees who contribute significantly to successful company performan |
|
| February 26, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 10-K 1 snmx2014123110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| February 26, 2015 |
Senomyx Announces FOURTH Quarter AND FULL YEAR 2014 Financial Results ex99-1.htm Exhibit 99.1 Senomyx Announces FOURTH Quarter AND FULL YEAR 2014 Financial Results SAN DIEGO, CA – February 26, 2015 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the fourth quarte |
|
| February 26, 2015 |
Exhibit 10.22 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE (this ?First Amendment?) is made as of February 19, 2015 (the ?First Amendment Date?), by and between ARE?NEXUS CENTRE II, LLC, a Delaware limited liability company (?Landlord?), and SENOMYX, INC., a Delaware corporation (?Tenant?). RECITALS A. Landlord and Tenant entered into that certain Lease Agreement dated as of January 12, |
|
| February 26, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition snmx201502258k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| February 26, 2015 |
Non-Employee Director Compensation Policy effective January 1, 2015. EX-10.11 2 ex10-11.htm EXHIBIT 10.11 EXHIBIT 10.11 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (1) (Effective January 1, 2015) ANNUAL CASH RETAINER • Annual retainer • $40,000 ADDITIONAL CHAIRMAN OF THE BOARD CASH COMPENSATION • Annual retainer • $30,000 ADDITIONAL LEAD INDEPENDENT DIRECTOR CASH COMPENSATION • Annual retainer • $20,000 ADDITIONAL COMMITTEE CHAIR CASH COMPENSATION • Annual retainer ( |
|
| February 26, 2015 |
snmx201502248k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| February 24, 2015 |
Entry into a Material Definitive Agreement snmx201502208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| February 17, 2015 |
SNMX / Senomyx, Inc. / Senvest Management, LLC - SENOMYX, INC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Senomyx, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| February 17, 2015 |
SNMX / Senomyx, Inc. / BANK OF AMERICA CORP /DE/ - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 03)* Senomyx, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| February 11, 2015 |
SNMX / Senomyx, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - SNMX AS OF 12/31/2014 Passive Investment SC 13G/A 1 snmx13gadec14.htm SNMX AS OF 12/31/2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11) SENOMYX INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of Statement) Check the appropriate box to designa |
|
| January 29, 2015 |
SNMX / Senomyx, Inc. / Lagoda Investment Management, L.P. Passive Investment THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SENOMYX, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| January 23, 2015 |
Costs Associated with Exit or Disposal Activities snmx20150121b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| January 23, 2015 |
snmx201501218k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2015 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| January 9, 2015 |
SNMX / Senomyx, Inc. CORRESP - - snmx20150107corresp.htm January 9, 2015 Ms. Cecilia Blye, Chief Office of Global Security Risk Division of Corporate Finance United States Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Re: Senomyx, Inc. Form 10-K for the Fiscal Year Ended December 31, 2013 Filed March 13, 2014 File No. 0-50791 Dear Ms. Blye, On behalf of Senomyx, Inc. (the “Company”), I hereby submit the |
|
| November 6, 2014 |
Senomyx Announces corporate update and third Quarter 2014 Financial Results snmx201411058k.htm Exhibit 99.1 Senomyx Announces corporate update and third Quarter 2014 Financial Results SAN DIEGO, CA – November 6, 2014 – Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the third qu |
|
| November 6, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition snmx201411058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission |
|
| November 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SENOMYX, INC. (E |
|
| August 11, 2014 |
PROSPECTUS Common Stock Preferred Stock Debt Securities Warrants Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. |
|
| July 31, 2014 |
SENOMYX, INC. , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20 EXHIBIT 4.8 SENOMYX, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20 SENOMYX, INC. FORM OF COMMON STOCK WARRANT AGREEMENT COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between SENOMYX, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corpor |
|
| July 31, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SEN |
|
| July 31, 2014 |
SENOMYX, INC., Issuer [TRUSTEE], Trustee Dated as of , 20 Debt Securities EXHIBIT 4.5 SENOMYX, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of , 20 Debt Securities Table of Contents Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee’s Certificate 8 Section 2.03 Den |
|
| July 31, 2014 |
SENOMYX, INC. , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20 EXHIBIT 4.9 SENOMYX, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20 SENOMYX, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENT PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between SENOMYX, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having |
|
| July 31, 2014 |
STATEMENT REGARDING COMPUTATION OF RATIOS Exhibit 12.1 STATEMENT REGARDING COMPUTATION OF RATIOS Year Ended December 31, Six Months Ended June 30, 2009 2010 2011 2012 2013 2014 (in thousands) Earnings: Net loss $ (26,165 ) $ (10,666 ) $ (8,724 ) $ (9,186 ) $ (11,898 ) $ (4,649 ) Add: Fixed Charges 811 732 646 553 451 185 Earnings as defined $ (25,354 ) $ (9,934 ) $ (8,078 ) $ (8,633 ) $ (11,447 ) $ (4,464 ) Fixed Charges: Estimated intere |
|
| July 31, 2014 |
Exhibit 99.1 SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS Recent Highlights Include: · Received FEMA GRAS regulatory determination for new cooling agent, S2227 · Granted JECFA regulatory approval for Sweetmyx® SR96 (S9632) · Notified of Allowance for New U.S. Patent Related to Sweetmyx S617 SAN DIEGO, CA — July 31, 2014 — Senomyx, Inc. (NASDAQ: SNMX), a leading comp |
|
| July 31, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 31, 2014 |
SENOMYX, INC. , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20 EXHIBIT 4.10 SENOMYX, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20 SENOMYX, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENT DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between SENOMYX, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and havin |
|
| July 31, 2014 |
SNMX / Senomyx, Inc. S-3 - - S-3 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on July 31, 2014 Registration No. |
|
| June 2, 2014 |
FIRST AMENDMENT TO RIGHTS AGREEMENT Exhibit 4.1 FIRST AMENDMENT TO RIGHTS AGREEMENT This FIRST AMENDMENT (the “Amendment”) to the Rights Agreement (the “Agreement”) entered into as of February14, 2005, by and between SENOMYX, INC., a Delaware corporation (the “Company”), and COMPUTERSHARE INC. (the “Rights Agent”), successor-in-interest to Mellon Investor Services LLC, is entered into as of May 30, 2014. RECITALS WHEREAS, Section 27 |
|
| June 2, 2014 |
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] Exhibit 99.1 AGREEMENT This Agreement (this “Agreement”) is entered into effective as of May 30, 2014 by and between RIMA Senvest Management, LLC (“RIMA”), Senvest Master Fund, L.P. (“Master Fund”), Richard Mashaal, (“Richard”), Senvest International L.L.C. (“International,” and together with RIMA, Master Fund, Richard and any Affiliate or Associate thereof, “Senvest”) and Senomyx, Inc., a Delawar |
|
| June 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 30, 2014 |
Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-0843840 |
|
| May 19, 2014 |
SENOMYX ANNOUNCES TWO-YEAR EXTENSION OF SWEET PROGRAM COLLABORATION WITH PEPSICO Exhibit 99.1 SENOMYX ANNOUNCES TWO-YEAR EXTENSION OF SWEET PROGRAM COLLABORATION WITH PEPSICO SAN DIEGO, CA — May 19, 2014 - Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that PepsiCo, Inc. has exercised its option to extend th |
|
| May 19, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-0843840 |
|
| May 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50791 SE |
|
| May 1, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-0843840 |
|
| May 1, 2014 |
Exhibit 99.1 SENOMYX ANNOUNCES CORPORATE UPDATE AND FIRST QUARTER 2014 FINANCIAL RESULTS Recent Highlights Include: · Established new collaborative agreement with PepsiCo, Inc. to identify new salt flavor modifiers · Expanded the Senomyx direct sales portfolio, which now includes four Complimyx® brand flavor offerings SAN DIEGO, CA — May 1, 2014 — Senomyx, Inc. (NASDAQ: SNMX), a leading company us |
|
| April 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 9, 2014 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 9, 2014 |
Exhibit 99.1 SENOMYX ENTERS INTO RESEARCH AGREEMENT WITH PEPSICO TO IDENTIFY NEW SALT FLAVOR MODIFIERS Partnership Focused on New Ingredients to Reduce Salt in Products SAN DIEGO, CA — April 9, 2014 Senomyx, Inc. (NASDAQ: SNMX), a leading company in using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industr |
|
| March 13, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 13, 2014 |
Form of Non-Employee Director Stock Option Agreement under the 2013 Equity Incentive Plan. EXHIBIT 10.7 SENOMYX, INC. 2013 EQUITY INCENTIVE PLAN NON-EMPLOYEE DIRECTOR (NONSTATUTORY STOCK OPTION) Pursuant to the Stock Option Grant Notice (the ?Grant Notice?) and this Option Agreement (this ?Option Agreement?), Senomyx, Inc. (the ?Company?) has granted you an option (the ?Option?) under its 2013 Equity Incentive Plan (the ?Plan?) to purchase the number of shares of the Company?s Common St |
|
| March 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-50791 SENOMYX, |
|
| March 13, 2014 |
Exhibit 99.1 SENOMYX ANNOUNCES CORPORATE UPDATE AND FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS Recent Highlights Include: · Received Generally Recognized As Safe (GRAS) determination for new Sweetmyx™ flavor ingredient, S617 · Received regulatory approval for Sweetmyx SR69 (S6973) sucrose modifier in the European Union SAN DIEGO, CA — March 12, 2014 — Senomyx, Inc. (NASDAQ: SNMX), a leadi |
|
| March 13, 2014 |
Form of Employee Stock Option Agreement under the 2013 Equity Incentive Plan. EXHIBIT 10.6 SENOMYX, INC. 2013 EQUITY INCENTIVE PLAN OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION) Pursuant to the Stock Option Grant Notice (the ?Grant Notice?) and this Option Agreement (this ?Option Agreement?), Senomyx, Inc. (the ?Company?) has granted you an option (the ?Option?) under its 2013 Equity Incentive Plan (the ?Plan?) to purchase the number of shares of th |
|
| March 11, 2014 |
EXHIBIT 99.1 SENOMYX ANNOUNCES RECEIPT OF GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR NEW SWEETMYX™ FLAVOR INGREDIENT * The new Sweetmyx flavor ingredient maintains the taste of reduced-sugar products * GRAS status allows usage in a broad range of foods & beverages in the U.S. and elsewhere SAN DIEGO, CA — March 11, 2014 — Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary |
|
| March 11, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-08438 |
|
| February 14, 2014 |
SNMX / Senomyx, Inc. / BANK OF AMERICA CORP /DE/ - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* Senomyx, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 14, 2014 |
SNMX / Senomyx, Inc. / RA Capital Management, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SENOMYX, INC. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 13, 2014 |
SNMX / Senomyx, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - SNMX AS OF 12/31/2013 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* SENOMYX INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81724Q107 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fil |
|
| February 10, 2014 |
SNMX / Senomyx, Inc. / Senvest Management, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2014 |
SNMX / Senomyx, Inc. / Senvest Management, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 7, 2014 |
Senomyx 2014 Executive Bonus Plan EX-99.1 2 a14-52741ex99d1.htm EX-99.1 EXHIBIT 99.1 Senomyx 2014 Executive Bonus Plan The Senomyx 2014 Executive Bonus Plan (the “Bonus Plan”) has been designed to align plan participants with the goals and business strategy of Senomyx, Inc. (“Senomyx” or “the Company”). This Bonus Plan is an important part of the Company’s commitment to recognize employees who contribute significantly to successfu |
|
| February 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2014 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50791 33-0843840 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 10, 2014 |
As filed with the Securities and Exchange Commission on January 10, 2014 Registration No. |
|
| January 10, 2014 |
Exhibit 99.1 SENOMYX, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 28, 2013 APPROVED BY THE STOCKHOLDERS: JUNE 13, 2013 AMENDMENT APPROVED BY THE BOARD OF DIRECTORS ON DECEMBER 11, 2013 (STOCKHOLDER CONSENT WAS NOT REQUIRED) 1. GENERAL. (a) Successor to and Continuation of Prior Plan. The Plan is intended as the successor to and continuation of the Senomyx, Inc. 2004 Eq |
|
| December 13, 2013 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2013 Senomyx, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-50791 (Commission File Number) 33-08 |
